Systemic Lupus Erythematosus
-
GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline
Congratulations to Chimagen and GSK!
-
【Product for Sale】Innovative Biological Product for Systemic Lupus Erythematosus (SLE)
If interested in this asset, please contact DrugTimes BD Team at BD@drugtimes.cn. Many thanks!
